Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01685021 |
|---|---|
| Brief Title: | Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL) |
| First Submitted : | September 3, 2012 |
| First Submitted that Met QC Criteria : | September 10, 2012 |
| First Posted : | September 13, 2012 (Estimate) |
| Results First Submitted : | March 4, 2016 |
| Results First Submitted that Met QC Criteria : | February 20, 2018 |
| Results First Posted : | February 22, 2018 |
| Last Update Submitted that Met QC Criteria : | February 20, 2018 |
| Last Update Posted : | February 22, 2018 |